AU2001277959A1 - Human kinases - Google Patents
Human kinasesInfo
- Publication number
- AU2001277959A1 AU2001277959A1 AU2001277959A AU7795901A AU2001277959A1 AU 2001277959 A1 AU2001277959 A1 AU 2001277959A1 AU 2001277959 A AU2001277959 A AU 2001277959A AU 7795901 A AU7795901 A AU 7795901A AU 2001277959 A1 AU2001277959 A1 AU 2001277959A1
- Authority
- AU
- Australia
- Prior art keywords
- human kinases
- kinases
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22003800P | 2000-07-21 | 2000-07-21 | |
| US60/220,038 | 2000-07-21 | ||
| US22211200P | 2000-07-28 | 2000-07-28 | |
| US60/222,112 | 2000-07-28 | ||
| US22283100P | 2000-08-04 | 2000-08-04 | |
| US60/222,831 | 2000-08-04 | ||
| US22472900P | 2000-08-11 | 2000-08-11 | |
| US60/224,729 | 2000-08-11 | ||
| PCT/US2001/023092 WO2002008399A2 (en) | 2000-07-21 | 2001-07-20 | Human kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001277959A1 true AU2001277959A1 (en) | 2002-02-05 |
Family
ID=27499171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001277959A Abandoned AU2001277959A1 (en) | 2000-07-21 | 2001-07-20 | Human kinases |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1356032A2 (en) |
| JP (1) | JP2004527209A (en) |
| AU (1) | AU2001277959A1 (en) |
| CA (1) | CA2416414A1 (en) |
| WO (1) | WO2002008399A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1484408A1 (en) * | 1999-09-28 | 2004-12-08 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| WO2001079488A2 (en) * | 2000-04-13 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | 14257,protein kinase molecules and uses therefor |
| US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
| EP1322768A2 (en) * | 2000-07-28 | 2003-07-02 | Chiron Corporation | Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| CA2421265A1 (en) * | 2000-09-05 | 2002-03-14 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
| WO2003023034A2 (en) * | 2001-09-12 | 2003-03-20 | Bayer Healthcare Ag | Regulation of human tau-tubulin kinase |
| WO2003076577A2 (en) * | 2002-03-05 | 2003-09-18 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2003084992A1 (en) * | 2002-04-05 | 2003-10-16 | Riken | Novel proteins and dnas encoding the same |
| JP2003289876A (en) * | 2002-04-05 | 2003-10-14 | Takeda Chem Ind Ltd | Preventive and/or therapeutic agent for cancer |
| US20050208492A1 (en) * | 2002-05-15 | 2005-09-22 | Jiing-Ren Liou | Regulation of human serine/threonine kinase |
| AU2003300027A1 (en) | 2002-10-10 | 2004-05-04 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| US7208306B2 (en) | 2002-10-24 | 2007-04-24 | Wyeth | Compositions employing a novel human protein phosphatase |
| JP2006514554A (en) | 2002-11-21 | 2006-05-11 | ワイス | Diagnosis of renal cell carcinoma and other solid tumors |
| AU2003290664A1 (en) | 2002-11-27 | 2004-06-23 | Wei Liu | Compositions, organisms and methodologies employing a novel human kinase |
| EP1604036A2 (en) * | 2003-03-20 | 2005-12-14 | Metabolex, Inc. | Compositions and methods of using hexokinase v |
| US20040265961A1 (en) * | 2003-03-28 | 2004-12-30 | Wei Liu | Novel proteins homologous to kinase suppressor of Ras |
| US20050125852A1 (en) * | 2003-05-09 | 2005-06-09 | Sugen, Inc. | Novel kinases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6183962B1 (en) * | 1998-09-09 | 2001-02-06 | Millennium Pharmaceuticals, Inc. | Protein kinase molecules and uses therefor |
-
2001
- 2001-07-20 EP EP01955908A patent/EP1356032A2/en not_active Withdrawn
- 2001-07-20 WO PCT/US2001/023092 patent/WO2002008399A2/en not_active Ceased
- 2001-07-20 JP JP2002513883A patent/JP2004527209A/en active Pending
- 2001-07-20 CA CA002416414A patent/CA2416414A1/en not_active Abandoned
- 2001-07-20 AU AU2001277959A patent/AU2001277959A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002008399A3 (en) | 2003-08-28 |
| WO2002008399A2 (en) | 2002-01-31 |
| CA2416414A1 (en) | 2002-01-31 |
| JP2004527209A (en) | 2004-09-09 |
| EP1356032A2 (en) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9517301A (en) | Implant | |
| AU2001241963A1 (en) | Improved medical procedure | |
| AU2002223827A1 (en) | Well treatment | |
| AUPQ899700A0 (en) | Probiotic recolonisation therapy | |
| AU2001260327A1 (en) | Chair | |
| AU2001263841A1 (en) | Implant | |
| AU2000267458A1 (en) | Hypercomputer | |
| AU2001254786A1 (en) | Medical implant | |
| AU2001220246A1 (en) | Neckphone | |
| AU2001239310A1 (en) | Decahydro-isoquinolines | |
| AU2001259702A1 (en) | Tissue regrafting | |
| AU2001280598A1 (en) | Anti-occlusion catheter | |
| AU2001288612A1 (en) | Human kinases | |
| AU2001268525A1 (en) | Human kinases | |
| AU2001277959A1 (en) | Human kinases | |
| AU2001238488A1 (en) | Human kinases | |
| AU2001233208A1 (en) | Human sulfatases | |
| AU2001247841A1 (en) | Medical procedure | |
| AU2292301A (en) | Human kinases | |
| AU2002227925A1 (en) | Human beta-defensin-3 | |
| AU2001270129A1 (en) | Human phosphodiesterases | |
| AU2001255573A1 (en) | Human kinases | |
| AU2001275723A1 (en) | Bougie | |
| AU2002227352A1 (en) | Human kinases | |
| AU2000243264A1 (en) | Human nim1 kinase |